Improved thiopurine formulations and methods of treatment

JP2025510301APending Publication Date: 2025-04-14DOUGLAS PHARMA
0 Cites 0 Cited by

Patent Information

Application Number
JP2024557241
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-03-25
Filing Date
2023-03-24
Publication Date
2025-04-14

Smart Images

  • Figure 2025510301000020
    Figure 2025510301000020
  • Figure 2025510301000021
    Figure 2025510301000021
  • Figure 2025510301000022
    Figure 2025510301000022
Patent Text Reader

Abstract

The present invention relates generally to improved formulations of 6-thioguanine (6-TG), their methods of preparation, and their use in methods of treatment. The present invention provides pharmaceutical compositions comprising 6-TG and a polyethylene oxide polymer having a molecular weight of about 900,000 g / mol to about 9,000,000 g / mol, their methods of preparation, and their use in methods for treating distal intestinal diseases or conditions responsive to 6-TG, wherein 6-TG is released in the distal intestine.
Need to check novelty before this filing date? Find Prior Art